Accéder au contenu
Merck

XRCC1 mediated the development of cervival cancer through a novel Sp1/Krox-20 swich.

Oncotarget (2017-11-22)
Qingtao Meng, Shizhi Wang, Weiyan Tang, Shenshen Wu, Na Gao, Chengcheng Zhang, Xiaoli Cao, Xiaobo Li, Zhengdong Zhang, Michael Aschner, Hua Jin, Yue Huang, Rui Chen
RÉSUMÉ

Cervical cancer is the second leading cause of mortality among women. Impairment of the base excision repair (BER) pathway is one of the major causes of the initiation and progression of cervical cancer. However, whether the polymorphisms of the BER pathway components (i.e.,

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Suplatast tosylate, ≥98% (HPLC)
Sigma-Aldrich
MISSION® esiRNA, targeting human EGR2